Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,800 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 9 Sepember 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 4MB, 239 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 7 results:
Author Title [ Type(Asc)] Year
Filters: Author is Dormuth, C. R.  [Clear All Filters]
Journal Article
C. R. Dormuth, Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., Lafrance, J. P., Levy, A., Garg, A. X., and Ernst, P., Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases, Bmj, vol. 346, p. f880, 2013.
C. Renoux, Lix, L. M., Patenaude, V., Bresee, L. C., Paterson, J. M., Lafrance, J. P., Tamim, H., Mahmud, S. M., Alsabbagh, M. W., Hemmelgarn, B., Dormuth, C. R., and Ernst, P., Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis, Clin J Am Soc Nephrol, vol. 10, pp. 1716-22, 2015.
K. B. Filion, Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., Teare, G. F., Ravani, P., Ernst, P., and Dormuth, C. R., Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis, Gut, vol. 63, pp. 552-8, 2014.
M. H. Secrest, Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., and Filion, K. B., Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example, Pharmacoepidemiol Drug Saf, 2019.
K. B. Filion, Azoulay, L., Platt, R. W., Dahl, M., Dormuth, C. R., Clemens, K. K., Hu, N., Paterson, J. M., Targownik, L., Turin, T. C., Udell, J. A., and Ernst, P., A Multicenter Observational Study of Incretin-based Drugs and Heart Failure, N Engl J Med, vol. 374, pp. 1145-54, 2016.
M. H. Secrest, Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., Doyle, C. M., Dell'Aniello, S., and Filion, K. B., Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research, Pharmacoepidemiol Drug Saf, 2019.
C. R. Dormuth, Winquist, B., Fisher, A., Wu, F., Reynier, P., Suissa, S., Dahl, M., Ma, Z., Lu, X., Zhang, J., Raymond, C. B., Filion, K. B., Platt, R. W., Moriello, C., and Paterson, J. M., Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort, JAMA Netw Open, vol. 4, p. e215329, 2021.
[Page last reviewed 9 September 2021]